Literature DB >> 6861077

Pain in metastatic breast cancer.

D Spiegel, J R Bloom.   

Abstract

The pain experiences of 86 women with metastatic carcinoma of the breast were systematically evaluated over a period of one year. Fifty-six percent of the sample reported experiencing pain, and the intensity of pain was not significantly related to site of metastasis. Multiple regression analysis revealed that 50% of the variance in the pain experience was accounted for by: (1) the amount of mood disturbance as measured by the Profile of Mood States (POMS); (2) the patients' belief that the pain indicated worsening of the illness; and (3) the use of analgesic medication. The nature of family support, social functioning, and coping responses were not significantly associated with pain intensity, nor was mortality during the one-year follow-up period. These data document the significance of psychological factors in accounting for differences in pain experience and document the interaction between pain and mood disturbance. These findings suggest that treatment of metastatic pain should include attention to the patient's mood and adjustment to the illness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861077     DOI: 10.1002/1097-0142(19830715)52:2<341::aid-cncr2820520227>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Hypnosis for symptom management in women with breast cancer: a pilot study.

Authors:  Mark P Jensen; Julie R Gralow; Alan Braden; Kevin J Gertz; Jesse R Fann; Karen L Syrjala
Journal:  Int J Clin Exp Hypn       Date:  2012

2.  Pain catastrophizing, pain intensity, and dyadic adjustment influence patient and partner depression in metastatic breast cancer.

Authors:  Hoda Badr; Megan J Shen
Journal:  Clin J Pain       Date:  2014-11       Impact factor: 3.442

3.  An evaluation of the quality of life among long-term survivors of breast cancer.

Authors:  K H Dow; B R Ferrell; S Leigh; J Ly; P Gulasekaram
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  A study of the needs of cancer patients and their relatives.

Authors:  B Herity; N Hilliard; M Moriarty; J Fennelly; R Conroy; M Casey
Journal:  Ir J Med Sci       Date:  1987-06       Impact factor: 1.568

5.  Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices.

Authors:  Louis Jacob; Laura Bleicher; Karel Kostev; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-16       Impact factor: 4.553

6.  Psychosocial correlates of sleep quality and architecture in women with metastatic breast cancer.

Authors:  Arianna Aldridge-Gerry; Jamie M Zeitzer; Oxana G Palesh; Booil Jo; Bita Nouriani; Eric Neri; David Spiegel
Journal:  Sleep Med       Date:  2013-09-05       Impact factor: 3.492

7.  Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer.

Authors:  Oxana Palesh; Jamie M Zeitzer; Ansgar Conrad; Janine Giese-Davis; Karen M Mustian; Varinia Popek; Karen Nga; David Spiegel
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

8.  Prevalence and correlates of pain in the Canadian National Palliative Care Survey.

Authors:  Keith G Wilson; Hervey Max Chochinov; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger
Journal:  Pain Res Manag       Date:  2009 Sep-Oct       Impact factor: 3.037

Review 9.  Psychosocial aspects of cancer pain.

Authors:  F Stiefel
Journal:  Support Care Cancer       Date:  1993-05       Impact factor: 3.603

10.  Sexual Adjustment and Body Image Scale (SABIS): a new measure for breast cancer patients.

Authors:  E Jane Dalton; Valaire Naisbitt Rasmussen; Catherine C Classen; Mareile Grumann; Oxana Gronskaya Palesh; Julia Zarcone; Helena C Kraemer; Jeffrey J Kirshner; Lauren K Colman; Gary R Morrow; David Spiegel
Journal:  Breast J       Date:  2009 May-Jun       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.